Enhabit (EHAB) Competitors $7.58 -0.22 (-2.76%) Closing price 03:58 PM EasternExtended Trading$7.54 -0.04 (-0.58%) As of 06:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock EHAB vs. AHCO, TDOC, GRAL, PNTG, AVAH, CDNA, FLGT, CSTL, FTRE, and LFMDShould you be buying Enhabit stock or one of its competitors? The main competitors of Enhabit include AdaptHealth (AHCO), Teladoc Health (TDOC), GRAIL (GRAL), The Pennant Group (PNTG), Aveanna Healthcare (AVAH), CareDx (CDNA), Fulgent Genetics (FLGT), Castle Biosciences (CSTL), Fortrea (FTRE), and LifeMD (LFMD). These companies are all part of the "healthcare" industry. Enhabit vs. Its Competitors AdaptHealth Teladoc Health GRAIL The Pennant Group Aveanna Healthcare CareDx Fulgent Genetics Castle Biosciences Fortrea LifeMD AdaptHealth (NASDAQ:AHCO) and Enhabit (NYSE:EHAB) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, risk, earnings, analyst recommendations, institutional ownership, profitability, valuation and dividends. Does the media favor AHCO or EHAB? In the previous week, AdaptHealth had 2 more articles in the media than Enhabit. MarketBeat recorded 12 mentions for AdaptHealth and 10 mentions for Enhabit. Enhabit's average media sentiment score of 0.44 beat AdaptHealth's score of 0.19 indicating that Enhabit is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AdaptHealth 1 Very Positive mention(s) 3 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Enhabit 1 Very Positive mention(s) 0 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more volatility & risk, AHCO or EHAB? AdaptHealth has a beta of 1.58, meaning that its stock price is 58% more volatile than the S&P 500. Comparatively, Enhabit has a beta of 1.68, meaning that its stock price is 68% more volatile than the S&P 500. Is AHCO or EHAB more profitable? AdaptHealth has a net margin of 2.49% compared to Enhabit's net margin of -12.84%. AdaptHealth's return on equity of 5.01% beat Enhabit's return on equity.Company Net Margins Return on Equity Return on Assets AdaptHealth2.49% 5.01% 1.77% Enhabit -12.84%2.72%1.25% Do analysts prefer AHCO or EHAB? AdaptHealth presently has a consensus target price of $13.40, suggesting a potential upside of 45.81%. Enhabit has a consensus target price of $8.67, suggesting a potential upside of 14.26%. Given AdaptHealth's stronger consensus rating and higher probable upside, research analysts plainly believe AdaptHealth is more favorable than Enhabit.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score AdaptHealth 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00Enhabit 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33 Which has stronger earnings & valuation, AHCO or EHAB? AdaptHealth has higher revenue and earnings than Enhabit. Enhabit is trading at a lower price-to-earnings ratio than AdaptHealth, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAdaptHealth$3.26B0.38$90.42M$0.5417.02Enhabit$1.03B0.37-$156.20M-$2.67-2.84 Do institutionals & insiders have more ownership in AHCO or EHAB? 82.7% of AdaptHealth shares are owned by institutional investors. 1.6% of AdaptHealth shares are owned by company insiders. Comparatively, 3.4% of Enhabit shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. SummaryAdaptHealth beats Enhabit on 13 of the 16 factors compared between the two stocks. Get Enhabit News Delivered to You Automatically Sign up to receive the latest news and ratings for EHAB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding EHAB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EHAB vs. The Competition Export to ExcelMetricEnhabitMedical Services IndustryMedical SectorNYSE ExchangeMarket Cap$394.97M$7.17B$5.44B$20.70BDividend YieldN/A2.85%4.61%3.67%P/E Ratio-2.8465.6629.7528.40Price / Sales0.3730.88449.4856.10Price / Cash1.9125.5336.4223.21Price / Book0.6617.878.184.33Net Income-$156.20M$243.10M$3.26B$996.14M7 Day Performance16.16%2.42%1.15%1.93%1 Month Performance3.90%-2.92%2.82%-0.54%1 Year Performance-10.97%21.32%28.41%14.79% Enhabit Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EHABEnhabit2.3297 of 5 stars$7.59-2.8%$8.67+14.3%-8.2%$394.97M$1.03B-2.8410,700News CoverageEarnings ReportAnalyst ForecastAHCOAdaptHealth3.9112 of 5 stars$9.51+4.4%$13.40+40.8%+2.2%$1.23B$3.26B15.9410,500Gap DownTDOCTeladoc Health2.6988 of 5 stars$6.91-0.9%$9.76+41.4%-3.0%$1.22B$2.57B-5.785,500GRALGRAIL1.1682 of 5 stars$32.77-1.4%$31.50-3.9%+87.1%$1.20B$125.60M-0.551,360Positive NewsUpcoming EarningsPNTGThe Pennant Group3.3881 of 5 stars$22.44+1.7%$33.80+50.6%-14.1%$760.73M$695.24M29.167,000News CoveragePositive NewsAVAHAveanna Healthcare0.7395 of 5 stars$3.87+3.3%$5.25+35.8%+69.4%$738.42M$2.02B189.2533,500Trending NewsCDNACareDx4.0871 of 5 stars$12.26+0.3%$29.33+139.3%-50.3%$699.45M$333.79M10.92740Earnings ReportAnalyst ForecastFLGTFulgent Genetics3.7615 of 5 stars$19.67+7.1%$25.33+28.8%-13.2%$606.12M$283.47M-12.001,313Earnings ReportAnalyst UpgradeGap UpCSTLCastle Biosciences3.2309 of 5 stars$19.53+27.4%$37.00+89.5%-26.7%$590.88M$332.07M-107.72540Earnings ReportAnalyst RevisionFTREFortrea4.0999 of 5 stars$6.20-3.5%$13.73+121.6%-70.5%$574.77M$2.70B-0.7215,500Earnings ReportAnalyst ForecastLFMDLifeMD2.3094 of 5 stars$12.10-2.0%$13.86+14.5%+23.1%$561.04M$212.45M-36.30230News CoverageAnalyst ForecastAnalyst Revision Related Companies and Tools Related Companies AHCO Competitors TDOC Competitors GRAL Competitors PNTG Competitors AVAH Competitors CDNA Competitors FLGT Competitors CSTL Competitors FTRE Competitors LFMD Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:EHAB) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | SponsoredShocked one of my clients with thisTrump Schedules Controversial 'Market Reset' for September 30 Behind closed doors, the White House has orde...Altimetry | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | SponsoredChina's 500 Million Year AdvantageThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enhabit, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enhabit With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
